ESR1 and neoplasm: Two of the 31 most differentially expressed genes between the ESR1-negative and ESR1-positive BRCA1 tumours, CD133 and MMP7 (Table 1), were evaluated by immunohistochemistry and immunofluorescence in an independent series of 15 BRCA1 tumours, previously classified as basal or luminal (Figure 2).